180 Life Sciences Corp. Banner Image

180 Life Sciences Corp.

  • Ticker ATNF
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
180 Life Sciences Corp. Logo Image
  • 1-10 Employees
  • Based in Palo Alto, California
180 Life Sciences Corp. (NASDAQ: ATNF) is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. 180 Life Sciences is leading the research into solving oneMore of the world’s biggest drivers of disease – inflammation. The Company is driving groundbreaking studies into clinical programs, which are seeking to develop novel drugs addressing separate areas of inflammation for which there are no effective therapies. The Company’s primary platform is a novel program to treat fibrosis using anti-TNF (tumor necrosis factor).
4.8 / 5.0 (4)

180 Life Sciences Corp. reports have an aggregate usefulness score of 4.8 based on 4 reviews.

180 Life Sciences Corp.

Most Recent Annual Report

180 Life Sciences Corp.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

180 Life Sciences Corp. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!